Analyzing Clinical Trial Experiences of Prostate Cancer Patients

N/ANot Yet RecruitingNCT05411354

Power Life Sciences Inc.400 enrolled

Overview

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Prostate Cancer

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been diagnosed with Prostate Cancer as identified by imaging * Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer * Patient is at least 18 years of age Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient has a ECOG score of 4

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial

Time frame: 3 months

Number of patients who remain in Prostate Cancer clinical trial until completion of clinical trial

Time frame: 12 months